Aura Biosciences AURA
NASDAQ AURA
$6.15 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aura Biosciences (AURA) Research & Development (2020 - 2026)

Updated

Aura Biosciences (AURA) posted Research & Development of $30.75 million for Q2 2026, up 34.4% from $22.88 million a year earlier and up 10.0% from the prior quarter.

Analysis

Aura Biosciences (AURA) Research & Development (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Aura Biosciences was $102.78 million, up 20.1% year-over-year; for FY2025, it came in at $90.3 million, up 23.2% from FY2024.

  • Annual Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 38.0% (FY2020 to FY2025).
  • In prior years, Aura Biosciences' Research & Development was $73.3 million in FY2024 (+12.4%), $65.23 million in FY2023 (+54.4%), $42.24 million in FY2022 (+67.9%) and $25.16 million in FY2021 (+39.5%).
  • The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q3 2020.
  • On a year-over-year basis, Research & Development increased in seven of the last eight quarters, with growth averaging 21.9%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 125.2%; the weakest was Q4 2025, with a decline of 2.0%.
  • According to Business Quant data, Research & Development for the three prior quarters was $27.96 million (Q1 2026), $21.9 million (Q4 2025) and $22.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Aura Biosciences 636.40 Mn 376.71 Mn - 30.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.75 Mn
Mar 31, 2026 27.96 Mn
Dec 31, 2025 21.90 Mn
Sep 30, 2025 22.18 Mn
Jun 30, 2025 22.88 Mn
Mar 31, 2025 23.34 Mn
Dec 31, 2024 22.33 Mn
Sep 30, 2024 17.04 Mn
Jun 30, 2024 16.88 Mn
Mar 31, 2024 17.05 Mn
Dec 31, 2023 20.28 Mn
Sep 30, 2023 15.43 Mn
Jun 30, 2023 15.12 Mn
Mar 31, 2023 14.41 Mn
Dec 31, 2022 13.16 Mn
Sep 30, 2022 11.29 Mn
Jun 30, 2022 9.51 Mn
Mar 31, 2022 8.28 Mn
Dec 31, 2021 7.98 Mn
Sep 30, 2021 6.37 Mn
API Access

Aura Biosciences Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=AURA&period=max&api_key=YOUR_API_KEY